When comparing NfL with other biomarkers used for neurodegenerative disease, many studies have used NfL alone and in conjunction with more disease-specific biomarkers not only to further understand the progression of disease but also to evaluate the potential of NfL as a biomarker32. This evidence concerns the gene NEFL and neurodegenerative disease.